$197.28
-0.23-0.12%
At Close: -
$197.28
00.00%
After Hours: 4:49 PM EDT
15 minutes delayed
Comments
Loading...
BeiGene (BGNE) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestBeiGene (NASDAQ:BGNE) Stock Quotes, Forecast and News Summary
BeiGene Stock (NASDAQ: BGNE) stock price, news, charts, stock research, profile.
| Open | $198.72 |
| Close | $197.28 |
| Volume / Avg. | 187.76K / 273.72K |
| Day Range | $197.00 - $199.99 |
| 52 Wk Range | 126.97 - 215.00 |
| Market Cap | $20.93B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 56 |
| Short Interest | 4.35% |
| Days to Cover | 8.26 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About BeiGene Ltd
Sector
Health Care
Industry
Biotechnology
BeiGene Ltd is a global oncology company that is discovering and developing innovative treatments th...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy BeiGene (BGNE) stock?
You can purchase shares of BeiGene (NASDAQ:BGNE) through any online brokerage.
Who are BeiGene (BGNE) competitors?
Other companies in BeiGene’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Roivant Sciences (NASDAQ:ROIV).
What is the forecast, or price target, for BeiGene (BGNE) stock?
BeiGene has a consensus price target of $262.46.
What is the current price for BeiGene (BGNE)?
The stock price for BeiGene (NASDAQ: BGNE) is $197.28 last updated September 18, 2024 at 4:49 PM EDT.
Does BeiGene (BGNE) pay a dividend?
There are no upcoming dividends for BeiGene.
When is BeiGene (NASDAQ:BGNE) reporting earnings?
BeiGene’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is BeiGene (BGNE) going to split?
There is no upcoming split for BeiGene.
What sector and industry does BeiGene (BGNE) operate in?
BeiGene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.